Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-23-000094

Chief Medical Officer acquired 5,018 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2023-12-11 Option exercise +5,018 $0.54 $2,710 20,069 D
Derivatives
Rodman David Malcom Chief Medical Officer 2023-12-11 Option exercise · Stock Option −5,018 65,224 D
Loading xslF345X05/wk-form4_1702418911.xml…